ArticleJAMA network open2021

Estimated Costs and Long-term Outcomes of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System.

Stephen B Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.